期刊文献+

正常孕妇早中晚孕期的甲状腺激素参考值范围 被引量:91

Trimester-specific reference data of thyroid hormones for normal pregnancy
原文传递
导出
摘要 目的建立正常孕妇早、中、晚孕期的甲状腺激素参考值范围,为诊断、治疗、监测(或筛查)孕妇甲状腺疾病以及相关研究提供参考。方法在碘营养充足地区一次性横断面调查孕妇及非妊娠妇女,通过统一设计的调查表和实验室检测结果严格筛选出505名不同孕期的正常孕妇和153名正常非妊娠妇女(作为对照),建立甲状腺激素参考值范围;甲状腺激素测定采用化学发光免疫测定方法,参考值范围采用中位数(P50)及双侧限值(P2.5和P97.5)表示。结果进入本研究的所有妇女家庭均食用加碘盐,她们的尿碘中位数均达到了适宜水平,表明这些妇女不存在碘缺乏或碘过量。孕妇的TSH水平在孕早期明显低于非妊娠妇女(P〈0.01),孕中期开始回升,但到孕晚期时仍未完全恢复到非妊娠水平;孕妇的n和瞩随妊娠时间逐渐下降,孕中期和孕晚期均明显低于非妊娠妇女(P〈0.01);孕妇的TT4和TT3自孕早期开始即明显升高(P〈0.01),至孕中期达峰值,大约是非妊娠的1.5倍。结论孕妇的甲状腺激素水平不同于非妊娠妇女,早、中、晚孕期之间也存在明显差异。因此,建立正常孕妇早、中、晚孕期的甲状腺激素参考值范围具有临床意义。 Objective To set up the trimester-specific reference ranges of thyroid hormones for normal pregnant women to provide reference criteria for diagnosis, treatment and monitoring or screening of thyroid disease during pregnancy and related research. Methods A cross-sectional survey was conducted in pregnant and nonpregnant women in iodine sufficient areas. A total of 505 normal pregnant women and 153 normal non-pregnant women (as control) were selected for establishing trimester-specific reference ranges of thyroid hormones after rigorous screening through the survey questionnaire and laboratory tests. Thyroid hormones were measured by Bayer automated chemiluminescence immunoassay, and the reference range of each hormone was calculated as median ( the 50th percentile value) and two-sided limits (the 2.5th and 97.5th percentile values). Results All women investigated were in iodine sufficient status within optimal urine iodine level. The serum TSH level during the 1 st trimester was obviously declined compared with that in the non-pregnant individuals (P 〈0.01 ), and started to rise during the 2nd trimester, but was still not restored to non-pregnant level until the 3rd trimester. Serum FT4 and FT3 levels gradually decreased from the 2nd trimester to the 3rd ( P 〈 0.01 ), and the TT4 and TY3 levels were markedly elevated since early pregnancy (P 〈 0. 01 ) and reached peak levels at the 2nd trimester approximately making up to 1.5 times of those in the non-pregnant individuals. Conclusion The thyroid hormone levels during pregnancy differ completely from those of the non-pregnant individuals, and also differ during different gestation periods. Therefore, to establish trimester-specific reference data of thyroid hormones during normal pregnancy may be important for clinical practice.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2008年第6期609-612,共4页 Chinese Journal of Endocrinology and Metabolism
基金 基金项目:卫生部应用研究课题(2005-01) 国家自然科学基金资助项目(30671816)
关键词 妊娠 甲状腺激素 参考值 Pregnancy : Thyroid hormones : Reference values
  • 相关文献

参考文献15

  • 1Kooistra L, Crawford S, van Baar AL, et al. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics, 2006, 17 : 161-167.
  • 2Matalon S, Sheiner E, Lavy A, et al. Relationship of treated maternal hypothyroidism and perinatal outcome. J Reprod Med, 2006,51 : 59- 63.
  • 3Akinci A, Sarac K, Gungor S, et al. Brain MR spectroscopy findings in neonates with hypothyroidism born to mothers living in iodinedeficiency areas. AJNR Am J Neororadiol, 2006,27:2083-2087.
  • 4Pop V J, Brouwers EP, Vander HL, et al. Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol, 2003,59:282-288.
  • 5Mitchell ML, Klein RZ. The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol, 2004,151 ( Suppl 3 ) : U45-48.
  • 6Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med, 1999,341:549-555.
  • 7American Thyroid Association. Consensus Statement 2: American Thyroid Association statement on early maternal thyroidal insufficiency:recognition, clinical management and research directions. Thyroid, 2005,15:77-79.
  • 8WHO Technical Consultation. Iodine requirements in pregnancy and infancy. IDD Newsletter, 2007,23 : 1-2.
  • 9Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines : Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003,13:3-126.
  • 10Stricker R, Eberhart R, Regli M, et al. Trimester-specific reference intervals for thyroid hormone assays on the Abbott Architect Analyzer. American Association for Clinical Chemistry Annual Meeting, Chicago, Illinois, 2006,23-27.

二级参考文献5

  • 1Engler H, Riesen W F, Keller B. anti-thyroid peroxidese (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method foe detection of anti-TPO (thyroid microsomal ) autoantibodies[J]. Clincs Chimica Acta, 225, 1994: 123-136.
  • 2Ponnusamy S,Colin M D.Thyoid autoantibodies[J]. Endocrinol Meta Clin North Ame,2001, 30: 315-337.
  • 3Libert F, Ruf J,Ludgate M,et al. Complete nucleotide sequence of the human thyroid peroxidese-microsomal antigen cDNA[J]. Nucl Acids Res, 1987,15: 6735.
  • 4P. Reed Larsen. Williams textbook of Endocrinology[M]. 10th ed. Philadelphia: Saunders, 2003. 360-365.
  • 5Estienne C, Duthoit C, Costanzo VD,et al. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters[J]. Euro J Endocrinol, 1999,141: 563-569.

共引文献13

同被引文献658

引证文献91

二级引证文献724

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部